Laura L. Carter

Biography

 Dr. Laura Carter brings nearly 15 years of scientific experience working in the pharmaceutical industry. Prior to joining Lycera, she was scientific director in the respiratory, inflammation and autoimmunity group at MedImmune, where she was responsible for overseeing research and development of treatments for autoimmune diseases such as systemic lupus erythematosus (SLE), rheumatoid arthritis and multiple sclerosis. Prior to MedImmune, she was a senior research investigator in the inflammation biology and translational science department at Array Biopharma and held scientific positions of increasing responsibility in the departments of inflammation/immunology and cardiovascular/metabolic diseases at Wyeth. Dr. Carter received an S.B. in biological science from Massachusetts Institute of Technology and a Ph.D. in molecular pathology from the University of California, San Diego School of Medicine.

Research Interest

 Development of treatments for autoimmune diseases such as systemic lupus erythematosus (SLE), rheumatoid arthritis and multiple sclerosis.